In HFD-induced NAFLD model, TLR-4/MyD88 signaling in liver parenchymal cells plays a pivotal role during the early progression of NAFLD, wherein high-mobility group protein B1 (HMGB1) served as a TLR4 activator [54]. This evidence concerns the gene MYD88 and metabolic dysfunction-associated steatotic liver disease.